The support from the Java Original Coffee Company helps us produce The Onco'Zine Brief and create awareness for difficult to treat cancers and topics including disparities in healthcare and access to cancer care as well as cancer prevention, -treatment and -diagnosis.
CHANDLER, Ariz. and NEW YORK (PRWEB) January 25, 2023
Today, the Java Original Coffee Company announced that it is partnering with The Onco’Zine Brief, a radio broadcast and podcast about research findings in cancer, as well as cancer prevention, - diagnoses, and - treatment, for an ongoing two-year sponsorship. As part of the agreement, a percentage of earnings from online premium coffee purchases will be set aside to support the production of new episodes of The Onco’Zine Brief, and expand the broadcast's syndication.
The sponsorship is part of the Java Original Coffee Company’s commitment to support the cancer (research) community and help physicians, including oncologists and hematologists (and other healthcare professionals) empower people, (cancer) patients and their family and friends with accurate information about cancer prevention, -diagnoses, -treatment.
Why cancer?
According to the American Cancer Society, overall cancer mortality has dropped 33% since 1991, averting an estimated 3.8 million cancer deaths. In a recent publication, the American Cancer Society, also said that in 2023 there are projected to be 1,958,310 new cancer cases and 609,820 cancer deaths in the United States. [1] Some of these cancers may be prevented by specific prevention strategies and early diagnosis. However, cancer prevention requires that people have the right information and access to healthcare. In creating the 'Shop-for-a-Cause/Make a Difference,' campaign, Java Original Coffee Company is committed to support 13 organizations involved in (cancer) research and treatment and in the development of continued education programs for physicians and ongoing healthcare information programs for (cancer) patient and their family & friends. As part of this commitment, Java Original Coffee Company donates 3.25% of earnings of all online purchases of premium roasted artisan coffees.
"We are really grateful to be chosen by the Java Original Coffee Company," said Peter Hofland, Ph.D., executive editor and co-publisher of Onco'Zine and ADC Review | Journal of Antibody-drug Conjugates and host of The Onco’Zine Brief.
"The focused commitment to support the development of continued education programs for physicians and information programs for (cancer) patient and their family & friends, makes the Java Original Coffee Company the perfect partner in helping us to create awareness for difficult to treat cancers, as well as discuss novel drug development, new and advanced cancer treatment modalities, prevention and (early) diagnosis, but also topics such as disparities in health and access to (cancer) care," he noted.
“Our plans for 2023 and 2024 includes increasing the number of programs and expand the syndication of The Onco'Zine Brief. The support we receive from the Java Original Coffee Company allows us to expand our reach so that The Onco’Zine Brief can be heard on-air in more cities in the United States. This support also helps us to expand our editorial and production team and, in collaboration with Onco'Zine and ADC Review | Journal of Antibody-drug Conjugates, offer additional programming during important medical society meetings in the United States, Europe and Asia," Hofland concluded.
About The Onco'Zine Brief
The Onco’Zine Brief is an interview and discussion program covering a broad range of topics and timely news updates with information from all oncology disciplines and sub-specialties from around the world. The program is a sponsor-supported broadcast and podcast for healthcare professionals involved in the management and care of cancer patients as well as cancer patients and their family and friends.
The Onco'Zine Brief is distributed in the United States via PRX (Public Radio Exchange). In the United Kingdom and Europe, the program is distributed via UK Health Radio (UKHR). The program can also be downloaded via most podcasts and streaming media services, including Audible, Spotify, Goodpods, Apple Podcast/iTunes, YouTube, SoundCloud, TuneIn, Google Podcasts, iHeart Radio and others.
For more information about how to sponsor or support The Onco’Zine Brief radio broadcast and podcast, schedule coverage of of conferences and/or medical society meetings (in association with Onco'Zine and ADC Review | Journal of Antibody-drug Conjugates), download our Media Kit or visit our Patreon page.
For more information about cancer and cancer treatments visit Onco'Zine. To sign up for The Onco'Zine Newsletter (open for residents of the United States only), text the word CANCER to 66866.
About Java Original Coffee Company
With a history dating back to 1842, the Java Original Coffee Company is the home of incredible artisan roasted gourmet coffee. Our mission is to offer the best artisan roasted coffee to our customers and create the best work environment, training, and support for our staff. We source our coffees from all over the world, and our seasonal whole bean coffee menu is curated to offer something special for everyone.
With our 'Shop-for-a-Cause/Make a Difference' campaign we donate a percentage of our earnings to support the cancer research community, individuals and organizations involved in the treatment of (pediatric) cancer patients, and organizations developing continued education programs for physicians and ongoing healthcare information programs for (cancer) patient and their family & friends.
In addition to sponsoring The Onco’Zine Brief, Java Original Coffee also donates a percentage of earnings from online premium coffee purchases to organizations including: St. Jude Children's Research Hospital; American Cancer Society; Breast Cancer Research Foundation; Phoenix Children's Hospital Foundation; Bear Necessities Pediatric Cancer Foundation; Ovarian Cancer Connection; GO2 Foundation for Lung Cancer; American Association For Cancer Research; Conquer Cancer Foundation; The Sarcoma Foundation of America; Lymphoma Research Foundation, and the Ben and Catherine Ivy Foundation.
Reference
Cancer Facts & Figures 2023, American Cancer Society. Online. Last accessed on January 17, 2023.